Microsaic Systems Share Discussion Threads

[k1ngkonggb] 07/9/2018 21:21

He's using his intuition...it's called a smartphone!!!

Arab, you a gooner?

[arab3] 07/9/2018 20:15

been out all day ?
you managed to post on 5 other boards !!

[ny boy] 07/9/2018 19:55

Been out all day, happy with progress, bottom forming here, offer is higher than it was yesterday, let’s seebwhat next week brings, have a good weekend all!

[parsons4] 07/9/2018 07:45

I agree NY Boy, No RNS but of course the purchase was under 3% it was not a Director which is a shame. But they are still well under valued.

[ny boy] 06/9/2018 16:10

6M buy @ 1.45 has been worked through, they have been dropping the share price for a few days to mug some sellers, looking good from here into 2019 when hopefully we get some real progress on sales.

Maybe Unicorn are adding, I think they bought 1.95p?

[ny boy] 06/9/2018 15:57

arab, so you bought in then, Unicorn better judge than me taking 16.43% in June, is a good indicator but not a banker bet, just comforting that they would have done 90% more due diligence than any of us PI’s!

I will hold for 2-5 years depending on future performance

[parsons4] 06/9/2018 15:56

I would not be surprised if the 6m is a purchase, maybe by a Director. This would show that they really have something worth much more than the present market cap !!

[ny boy] 06/9/2018 15:34

Hold up bid closed to 1.45p to sell, we’re going north

[ny boy] 06/9/2018 10:28

Base building here, this should be substantially higher next autumn onwards. Nice that you can still accumulate sub 1.5p GLA

[ny boy] 04/9/2018 15:25

It will be interesting to see if Unicorn add at these levels.

Signs of buyers looking for long term opportunities here today, early days but you have to be brave & confident to buy before the crowd, I have done some research and happy to have taken a stake here, not as big as Unicorn but decent. GLA

[dr biotech] 04/9/2018 12:11

I've yet to see a fund manager thats infallible - and there are many who are hopeless. I am not saying that Unicorn fall into this category, but I wouldn't ever buy into a share just on the basis of a fund manager buying in (or selling out etc). Most companies that go belly up will have some institution on board.

I just don't think this product is going to fly - may be some niche market for it, but I can't see them making anything like the numbers they are predicting. If they signed an agreement with a big player - Waters/Agilent/Thermo then it may be different. Knauer are a decent small company, but I never see their equipment in any of the big pharma labs.

[k1ngkonggb] 04/9/2018 10:53

Dr Biotech, but alot depends on this link up with the Big Biopharma. They did mention the strategy to focus on application areas in bioprocessing and diagnostics.

Directors have set internal targets for 2022 of sales of approximately 390 to 450 MS instruments and revenues of between £17 million to £19 million. The Directors have estimated that approximately 70 per cent would come from the bioprocessing market in 2022 and the balance would come from the Company's traditional small molecule market. The targeted revenues include recurring revenue in the form of consumables and service fee income.

Lets see where this progresses by year end then time to evaluate. Unicorn Asset Management have obviously done their due diligence so why invest into over 16% of share capital.

[dr biotech] 04/9/2018 10:32

I wouldn't touch these.

Their single quad MS is interesting tech, but not game changing. It doesn't offer the resolution of a benchtop - it can't match a triple Quad for flexibility (or the capability for MS/MS) and it doesn't have the mass range of a ToF which is often better for large biomolecules.

I've been to a lot of production facilities in the UK and they all have full LC/MS systems to hand. A new LCMS costs around £150k (you can pick up a decent used system for about 30-40k. They are moderately complex and need someone who knows what they are doing, but once set up they can run samples every few minutes (uplc). I don't know of any manufacturers with off site facilities (admittedly as I work with the labs I wouldn't go to a site without a lab).

I know the people at Omicron in the UK. They are a small distributor with a handful of employees. I see them regularly enough and will ask them if they have had any traction with their customers.

Looking at the results I wonder if they will ever sell enough to cover their expenses. I'm not sure they will ever turn in a profit.

I hope I am wrong - the UK has a strong history in MS and it would be nice to see them succeed, but I won't be putting my money on it.

[k1ngkonggb] 04/9/2018 10:25

Difference this time is much of their R&D has been completed although they did highlight that they will still be investing into that area. Also, they're ramping up their Sales now, alot more than over the last two years. I suspect that they're banking on this big Biopharma programme which by next year (if it comes to final completion and fruition) will be game changing.

It's one of those companies that does require patience, unlike some AIM listings.

[thetrophyman] 04/9/2018 10:10

They also raised £5.4m in August 2016 as I said last night by a placing which was issued to market in September... that looks like a £2.7m cash burn per year? Any thoughts would be welcome

[parsons4] 04/9/2018 07:15

Big players have joined here. The company is valued at a little more than cash. This of course is nothing for an AIM company because many investors are so short term. The biggest problem with MSYS is that it is difficult to understand the instruments that they are developing and what they achieve in the bio-processing market all IMHO of course. I think the cash position is strong and any sign of big orders and we have a 10 bagger !!!

[k1ngkonggb] 03/9/2018 22:17

They raised over 5.5m in July this year.

[thetrophyman] 03/9/2018 21:55

I bought in today, just a small amount though... but did they not raise about 5m in the summer of 2016? I was looking through some old RNSs earlier on but can't access right now...

[milliecusto] 03/9/2018 21:21

These will drift under 1p, no forecast on Turing a profit, cash in bank down to more dilution, further news required to see if a profit can be turned

[ny boy] 03/9/2018 14:01

Still putting through some large trades as sells on L2! 270,000 was a buy ffs!